Hillsdale Investment Management Inc. Astrazeneca PLC Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 22, 2021	SELL	$47.16 - $54.44 $4,716 - $5,444	-100 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $2,911 - $3,481	-60 Reduced 37.5%	100 $5,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $3,714 - $4,277	70 Added 77.78%	160 $9,000
Q2 2020 Aug 11, 2020	BUY	$43.1 - $55.31 $3,879 - $4,977	90 New	90 $5,000

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $211B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.